Longevity Vision Fund (LVF) is a venture capital fund that invests in technologies with the potential to disrupt life sciences and healthcare to help people live longer, healthier lives. The fund’s mission is to accelerate longevity breakthroughs, and to make them accessible and affordable to everyone
LVF provides venture funding (Series A-C / crossover) to health tech, longevity and biotech companies across the following sectors:
- Therapeutic & Drug Delivery Platforms
- Medical Technologies & Devices
- Preventive Medicine & Early Diagnostics
- Artificial Intelligence (AI) in Healthcare
Company Details
- Employees
- 6
- Founded
- -
- Address
- 555 Madison Avenue,
- Industry
- Venture Capital And Private Equity Principals
- NAICS
-
Miscellaneous Intermediation
- Website
- http://www.lvf.vc
- HQ
- New York, New York
Longevity Vision Questions
Longevity Vision's website is http://www.lvf.vc
Longevity Vision's LinkedIn profile is https://www.linkedin.com/company/longevityvision
Longevity Vision has
6 employees.
View email and phone details for 6
employees at Longevity Vision.
Longevity Vision's industry is
Venture Capital and Private Equity Principals
Longevity Vision's top competitors are
The Longevity Fund,
Apollo Health Ventures,
Biolinq,
Longevity Biotech Fellowship,
Atlantic Council,
Longevc,
Age1,
10x Capital,
Bold Longevity Growth Fund,
Peak State Ventures.
Longevity Vision's categories are Venture Capital and Private Equity Principals
Longevity Vision's founding year is 2019
